Ido Yofe

Rehovot, M 76100, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

ZEB2 is a master switch controlling the tumor-associated macrophage program.

ZEB2 is a master switch controlling the tumor-associated macrophage program.

Journal: Cancer cell
Published: July 15, 2024

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols.

Journal: Nature cancer
Published: September 03, 2023

Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma.

Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma.

Journal: Cell
Published: May 02, 2023

Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary.

Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary.

Journal: Cancer discovery
Published: March 11, 2023

Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Author Correction: Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Journal: Nature cancer
Published: November 14, 2022

Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

Journal: Nature medicine
Published: January 13, 2022

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signaling.

Journal: Nature cancer
Published: October 11, 2021

DestVI identifies continuums of cell types in spatial transcriptomics data.

DestVI identifies continuums of cell types in spatial transcriptomics data.

Journal: Nature biotechnology
Published: May 10, 2021

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis.

Journal: Nature medicine
Published: June 16, 2020

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Journal: Cell
Published: May 04, 2020

Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer.

Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer.

Journal: Cell
Published: January 16, 2020

Single-cell genomic approaches for developing the next generation of immunotherapies.

Single-cell genomic approaches for developing the next generation of immunotherapies.

Journal: Nature medicine
Published: September 03, 2019
Showing 1-12 of 28

Last Updated: 09/26/2026